Difference between revisions of "Team:NortheasternU-Boston/Collaborations"

Line 15: Line 15:
 
           <div class="collaborations-panel">
 
           <div class="collaborations-panel">
 
             <h3>NEGEM Meetup</h3>
 
             <h3>NEGEM Meetup</h3>
           <p>We shared our progress with Tufts, Boston University, WPI, Harvard, and MIT on June 21. We got feedback on running killing assays. We also heard concerns that AMPs are not suitable for clinical distribution, which caused us to focus on the foundational advance of post-translational modifications. We also completed surveys for WPI on lead contamination and for BU Hardware on microfluidics in synthetic biology.</p>
+
           <p>We shared our progress with Tufts, Boston University, WPI, Harvard, and MIT on June 21. We got feedback on running killing assays and also heard concerns that AMPs were not suitable for clinical distribution. This feedback helped us to refine our focus on the foundational advance of post-translational modifications. We also completed surveys for WPI on lead contamination and for BU Hardware on microfluidics in synthetic biology.</p>
 
             <div class="row collab-section-header">
 
             <div class="row collab-section-header">
 
               <div class="col-sm-3">
 
               <div class="col-sm-3">
Line 24: Line 24:
 
               </div>
 
               </div>
 
             </div>
 
             </div>
           <p>We talked to team INSA-UPS, who is working on AMPs for combatting cholera, about their project our projects and possible collaborations in addition to completing their survey about a hypothetical water treatment device. We gave troubleshooting advice but were unable to test each other's’ parts due to timing.</p>
+
           <p>We talked over Skype and email to team INSA-UPS concerning their work with AMPs for combatting cholera. We gave them feedback about their project and possible collaborations between our group including the opportunity for us to try to produce one of their AMPs in our cell-free reaction. Unfortunately the timing for this collaboration didn't pan out. In addition we completed their survey about a hypothetical water treatment device. We gave troubleshooting advice but were unable to test each others’ parts.</p>
 
             <div class="row collab-section-header">
 
             <div class="row collab-section-header">
 
               <div class="col-sm-3">
 
               <div class="col-sm-3">

Revision as of 20:13, 1 November 2017

Collaborators

NEGEM Meetup

We shared our progress with Tufts, Boston University, WPI, Harvard, and MIT on June 21. We got feedback on running killing assays and also heard concerns that AMPs were not suitable for clinical distribution. This feedback helped us to refine our focus on the foundational advance of post-translational modifications. We also completed surveys for WPI on lead contamination and for BU Hardware on microfluidics in synthetic biology.

INSA-UPS

We talked over Skype and email to team INSA-UPS concerning their work with AMPs for combatting cholera. We gave them feedback about their project and possible collaborations between our group including the opportunity for us to try to produce one of their AMPs in our cell-free reaction. Unfortunately the timing for this collaboration didn't pan out. In addition we completed their survey about a hypothetical water treatment device. We gave troubleshooting advice but were unable to test each others’ parts.

Boston U

We also talked to BU Wetlab team working on cell-free expression for RNA controlled switches. We compared cell free protocols and discussed challenges in using the expression system but did not have time to test each other’s parts.